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Abstract 
Elastin-like recombinamers (ELRs), which derive from one of the repetitive domains 
found in natural elastin, have been intensively studied in the last few years from several 
points of view. In this mini review, we discuss all the recent works related to the 
investigation of ELRs, starting with those that define these polypeptides as model 
intrinsically disordered proteins or regions (IDPs or IDRs) and its relevance for some 
biomedical applications. Furthermore, we summarize the current knowledge on the 
development of drug, vaccine and gene delivery systems based on ELRs, while also 
emphasizing the multiple tissue engineering approaches involving their use. Finally, we 
show different studies that explore applications in other fields, and several examples that 
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describe biomaterial blends in which ELRs have a key role. This review aims to give an 
overview of the recent advances regarding ELRs and to encourage further investigation 
of their properties and applications. 
Introduction 
As described in previous sections of this special issue, elastin is one of the main 
components of the extracellular matrix (ECM), and it is involved in conferring elasticity 
to a variety of organs and tissues, such as lungs, skin and blood vessels, among others, 
while also contributing to cell signaling [1]. Formed by the lysyl oxidase-mediated cross-
linking of lysine residues present in its soluble precursor, tropoelastin, it is composed of 
highly repetitive and well-conserved domains, including the hydrophobic Val-Pro-Gly-
Val-Gly (VPGVG) pentapeptide, first described by Gray et al. [2]. Soon after that, Urry’s 
laboratory became interested in the synthesis of this motif to investigate the features of 
elastin in a feasible way, in order to shed light on the pathophysiology of several diseases 
in which elastin is directly involved, hence developing the first elastin-like 
(poly)pentapeptides (ELPs) [3-5]. These ELPs showed an inverse temperature transition, 
meaning that they remained soluble below the so-called transition temperature (Tt), and 
they aggregated when the temperature was raised above approximately 25ºC. Moreover, 
physicochemical studies concluded that changes in the fourth amino acid of the 
pentapeptide led to alterations in the Tt, giving flexibility to the ELP design, since the 
basal monomer became VPGXG, where X (the guest residue) can be any amino acid 
except proline [6]. However, one of the major limitations at this point was that these 
primitive ELPs were chemically synthesized, hindering the achievement of long 
polypeptides. This issue was addressed with the advent of the recombinant DNA 
technology during the nineteen-eighties, which was easily adapted for the expression of 
structural protein polymers in heterologous hosts, mainly Escherichia coli [7-10] (Fig. 
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1). It also increased the versatility of the ELPs, allowing the combination of different 
structural protein domains [8], or the inclusion of bioactive amino acid sequences [11]. 
Furthermore, the polymeric and recombinant nature of these ELPs led to a new 
nomenclature proposed by Rodríguez-Cabello et al., elastin-like recombinamers (ELRs), 
in order to recapitulate both features in a single term [12]. 
 
Fig. 1. Schematic representation of the recombinant synthesis of ELRs and their 
reversible transition above the Tt. 
In the last years, a significant effort has been made to achieve novel ELR designs to 
extend the fields of application of this biopolymer. In this regard, several approaches for 
a comprehensive ELR development have been described, including Tt prediction [13] and 
the study of the effect of proteins fused to the ELRs in its recombinant expression [14] 
and self-assembly [15]. Moreover, different computational methods have been validated 
to elucidate the molecular mechanisms involved in the transition from a soluble to an 
aggregated state (above the Tt) of ELRs with different compositions, which may help in 
the anticipation of the physicochemical properties of novel recombinamers [16-19]. 
In this review, our aim is to give an overview of the most ‘trendy’ strategies described in 
the literature regarding the design and use of ELRs as biomaterials in different fields. 
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First, we will discuss works describing how ELRs can be considered model intrinsically 
disordered proteins (IDPs) and how they can help in the general study of this class of 
polypeptides. Furthermore, we will comment the diverse applications inferred from the 
control of their ordered-disordered state. Moreover, while several publications have 
already reviewed the use of ELRs in drug delivery [20, 21] and in tissue engineering and 
regenerative medicine (TERM) [1, 22-24], herein we will point out the major advances 
in the multi-purpose design and use of ELRs in these fields in the past few years. Finally, 
we will describe other designs and applications that do not completely fit into the 
aforementioned sections. 
ELRs as model intrinsically disordered proteins 
Traditionally, protein functionality was associated with the ability of polypeptide chains 
to fold into 3D structures, following the classical structure-function paradigm [25]. 
However, during the last decades, the increasing number of structural studies have shed 
light on the functional key role of intrinsically disordered regions (IDRs) and proteins 
(IDPs), which represent 40% of the eukaryotic proteome [26]. Furthermore, they are 
characterized by low complexity sequences, mainly hydrophilic, high content in proline 
and they are usually found in an unfolded state [27]. However, their flexibility enables 
them to interact with several different targets and to respond to different stimulus, folding 
into diverse dynamic molecular assemblies [28, 29], which may undergo phase transitions 
[30]. Thus, IDRs have been found to play a crucial role in cellular communication and 
gene regulation [31]. Moreover, mutations in their sequences are involved in the 
development of several human pathologies [32]. 
From the structural point of view, some protein polymers, such as ELRs or resilin-like 
polypeptides, fit into the description of IDRs and IDPs, i.e. they are made of the repetition 
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of low-complexity sequences with high content in proline and glycine [33], and they 
undergo phase transitions under selective solution conditions, such as specific 
temperature, pressure or pH [34]. Therefore, since a few years ago, they have been 
considered as model IDRs or IDPs, and studied accordingly [35, 36]. In addition, their 
recombinant nature and the feasibility to tune their sequence make them perfect 
candidates to mimic complex IDRs and study their function and behavior in solution [36, 
37]. For instance, depending on the chemical nature of the guest residue of the elastin-
like pentapeptide (VPGXG), we can control the propensity of the sequence to be 
disordered or, on the contrary, to collapse, thus shedding light on the phase separation 
process of IDRs. 
Regarding the evaluation of the physicochemical properties of ELRs, Zhang et al. 
provided an experimental structural model for the study of the early stages of the phase 
separation behavior [38]. A 40-pentapeptide ELR suitable for nuclear resonance 
measurements was developed based on a polyVPGVG that contained a different guest 
residue every seven pentapeptides (Lys, Thr, Ala, Ile, Ser and Leu). Therefore, it was 
possible to analyze the influence of every single non-valyl amino acid as guest residue 
(all the aforementioned except for Ile) on the phase transition. By complementing the 
chemical characterization with computational simulations, they demonstrated that a 
monomeric ELR behaved as random coils with a small compaction, even if the structure 
was folded up to 90% into β-turns. Consistently with previous results [39, 40], they 
suggested that oligomer coacervation is triggered by the temperature-dependent 
hydrophobic collapse and that, despite the formation of transient β-turns during this 
process, the intrinsic disorder of the monomers is maintained in this aggregated state. 
Furthermore, many IDRs are involved in the formation of subcellular protein 
compartments due to their phase separation behavior [41], which implies that ELRs may 
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be used as a model to form and study membraneless organelles. In this way, ELR collapse 
and phase separation allowed to develop subcellular compartments in mammal cells, 
controlling the clathrin-mediated endocytosis with an ELR fused to clathrin light chain 
[42], and to produce membraneless organelle-like structures in bacteria with a modular 
design based on an amphiphilic ELR [43]. This ELR was also used to produce artificial 
subcellular compartments based on nanovesicles that were able to encapsulate cellular 
reactions and processes such as transcription and translation [44]. The protein membranes 
of the vesicles were non-permeable to small molecules, allowing the specific separation 
of both processes. Moreover, their dynamic behavior and their ability to grow and 
generate protocellular compartments was demonstrated. In addition, even the amphiphilic 
ELR itself was translated inside the vesicles, and the monomers were incorporated within 
the vesicular membrane upon synthesis. 
Applications derived from the order-disorder balance in ELRs 
The control of disorder in ELRs may play a significant role for their use in biomedical 
applications. For instance, several studies have highlighted the contribution of scaffolds 
made of disordered proteins in the biomineralization process [45-47]. In this regard, ELRs 
have demonstrated their promising potential for the development of a great variety of 
structures that control mineralization due to their flexibility to self-assemble into diverse 
conformations. Hence, nanoparticles [48], 3D matrices [49, 50], and even 
nanotopographical hybrid surfaces that enable enzyme-directed mineralization [51] have 
been achieved, all of them mimicking the mechanical properties of native hard tissues. 
However, it is important to emphasize how the balance between order and disorder in 
ELR scaffolds influences the mineralization process. Li et al. developed bone fibrils made 
of ELRs that mimic collagen ones and demonstrated that their ordered structure is crucial 
for intrafibrillar mineralization [52]. In fact, the incorporation of short charged sequences 
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within the ELR monomers seemed to prevent their folding into ordered β-spiral 
structures, predetermining, in this way, the effectiveness of the mineralization via a 
polymer-induced liquid-precursor (PILP) process, which implied that the decrease in the 
order of the fibrillar microstructures involved a reduction of the mineral density. 
Similarly, Elsharkawy et al. produced mineralized ELR-based membranes with potential 
applicability for enamel regeneration [53]. The membranes provided a functional acid-
resistant scaffold for the nucleation and growth of hydroxyapatite. In addition, it was 
possible to control and tune the formation of hierarchical mineralized structures and their 
mechanical properties through the regulation of the crosslinking degree of the ELR 
molecules within the membranes, which influenced the order-disorder balance. 
The order-disorder equilibrium is also important to adjust the mechanical properties of 
injectable hydrogel scaffolds intended for tissue regeneration. In a recent work, Roberts 
et al. developed a molecular design based on alternating ordered polyalanine motifs with 
intrinsically disordered ELR domains to produce injectable porous scaffolds [54]. In this 
work, the authors showed that the interactions between the polyalanine α-helixes enabled 
the formation of kinetically stable 3D polypeptide networks, improving their mechanical 
properties in a similar way to the introduction of other ordered domains that form stable 
links/bonds and stabilize non-covalently cross-linked hydrogels, such as leucine zippers 
[55]. Moreover, they studied the modular distribution of the α-helix structures and 
demonstrated that their introduction within the ELR backbone strongly affects phase 
separation and hydrogel porosity, observing thermal hysteresis in the phase transition 
behavior. Therefore, the fine-tuning of the ratio between both domains and their 
composition provided a way to control the aggregation temperature and the mechanical 
properties of the ELR-based scaffolds. 
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The modular design and functional versatility of ELRs open up a range of possibilities 
for the development of covalent coatings for indwelling biomedical devices. In this way, 
their biocompatibility can be improved through the addition of different 
biofunctionalities, in order to avoid the failure of the biomaterial upon implantation, 
mainly by rejection (foreign body response) or infection (Fig. 2). In this sense, ELR 
coatings provide an ECM-like environment that helps to elude unspecific protein 
adsorption, and that can be tuned to increase the cytocompatibility of the devices, for 
example, through the inclusion of cell adhesion sequences [56, 57]. Furthermore, it could 
be possible to produce ELR patterns with diverse biofunctional domains to control the 
adhesion of different types of cells on different areas of the coating [58, 59]. Moreover, 
biomimetic ELR coatings for biomedical devices can be combined with antimicrobial 
peptides (AMPs), which are immunomodulatory short cationic peptides with broad-
spectrum antimicrobial activity and constitute one of the most promising alternatives to 
overcome bacteria resistance to conventional antibiotics [60]. This strategy has recently 
been described for the development of ELRs with covalently linked AMPs to produce 
anti-biofilm coatings for titanium implants, enhancing osteogenic differentiation and 
preventing the colonization of the devices by pathogenic bacteria [61]. In addition, ELRs 
provide a scalable method for the production of novel antimicrobial materials by 
incorporating AMPs into their backbone through recombinant DNA technology, thus 
overcoming the expensive chemical production of AMPs, which hampers their large-
scale production. In this regard, ELRs have demonstrated their potential for recombinant 
production and non-chromatographic purification of a broad range of proteins [62], which 
may include AMPs, and they can also boost the antimicrobial effect of these peptides 
when used in the formation of anti-biofilm coatings. In a still unpublished work, we have 
found that the low-fouling properties of the ELRs, which prevent unspecific protein 
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adsorption, converge synergistically with the antimicrobial properties of an AMP when 
both are recombinantly co-produced (Acosta et al., in press). Lastly, ELRs have been 
used to control the supramolecular assembly of AMPs to enhance their effectiveness. For 
instance, an AMP-ELR able to self-organize into different structures has been described, 
allowing the formation of nanoparticles that allow a controlled delivery [63] or films that 
inhibit bacterial and fungal infection during wound healing [64]. 
 
Fig. 2. Schematic illustration of different biomaterial surfaces functionalized with ELR 
coatings and their properties. 
Drug, vaccine and gene delivery systems based on ELRs 
ELRs have been used in the last decades for the development of drug delivery systems 
(DDS) by following different approaches, mainly the recombinant conjugation of 
pharmacological polypeptides and the use of drugs as cargo of nanoparticles (NPs) and/or 
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hydrogels. Moreover, within this section we will also consider immunomodulatory ELRs 
that act as vaccines, and the use of these recombinamers as gene delivery vectors. 
ELRs in drug delivery 
As aforementioned, recombinant DNA technology permits the genetic fusion of peptides 
or proteins to the ELRs, giving the opportunity of improving their functionality to almost 
an infinite extent. By these means, interferon alpha (IFN-α) was fused to an ELR, which 
not only simplified its purification by inverse transition cycling (ITC), but also improved 
the pharmacokinetics and tumor accumulation of the drug by increasing its circulating 
half-life [65]. Similarly, stromal cell-derived growth factor-1 (SDF1), which promotes 
vascularization, hence enhancing and accelerating re-epithelialization of skin wounds, 
was fused to an ELR, resulting in a faster wound healing in a diabetic mice model in 
comparison with the SDF1 by itself [66]. Another example of pharmacologically active 
ELRs implied the fusion of the fibroblast growth factor 21 (FGF21), a metabolic regulator 
that enhances insulin sensitivity, thus being a potential treatment for type 2 diabetes [67]. 
This fusion improved the solubility of the protein drug in E. coli, hence avoiding further 
refolding steps needed when inclusion bodies are formed during expression of FGF21 in 
this host. Moreover, the delivery of the ELR-FGF21 increased the half-life of the growth 
factor, so fewer injections were needed for a sustained pharmacological effect. An 
alternative to the fusion protein drugs is the use of peptides, whose activity does not 
usually require a complex folding, so they can be easily expressed in prokaryotic hosts 
such as E. coli. In this regard, the so-called ‘mini cry’ peptide, derived from the intra-
vitreal αB crystallin protein, which was found to protect retinal pigment epithelium (RPE) 
cells from oxidative stress-induced cell death, was genetically conjugated to an ELR to 
improve the retention of the bioactive peptide from 0.4 to 3.0 days [68]. According to this 
result, the ELR-mini cry was proposed as a potential DDS to prevent RPE atrophy and 
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progressive age-related macular degeneration. To further increase the circulation time in 
plasma of ELRs and ELR particles, novel zwitterionic polypeptides (ZIPP) were designed 
by introducing cationic and anionic amino acids within the same elastin-like pentapeptide 
[69]. The results showed that the combination of lysine and glutamic acid improved 
pharmacokinetics, an effect that was successfully leveraged to obtain a more sustainable 
delivery of glucagon-like peptide-1, used for the treatment of type 2 diabetes, when fused 
to the ZIPP. 
Another different but classical approach, which is also more versatile because other than 
protein drugs can be delivered, is the loading of nanoparticles or hydrogels with 
pharmacologically active compounds. In this last regard, it has been reported the 
formation of elastin-like (EL) and silk-elastin-like (SEL) hydrogels loaded with timolol 
maleate (TM), a drug used in the treatment of glaucoma to reduce the intraocular pressure 
[70]. The retention of TM was improved without eye irritation, an effect that was even 
more marked for SEL hydrogels, due to the higher stability obtained by the cross-linking 
of silk-like domains [71]. Therefore, both EL and SEL hydrogels were proposed as 
delivery systems in ophthalmic applications. As concerns the use of ELR particles as 
DDS, some design improvements have been achieved in the past few years to overcome 
different limitations, such as low plasma half-life, similarly to the aforementioned ZIPPs. 
For instance, an albumin-binding domain (ABD) was fused to an ELR, and the well-
known antitumor drug doxorubicin (DOX) was conjugated to the resulting ABD-ELR 
[72]. The whole system was found to self-assemble into spherical micelles, and the 
delivery of DOX with the ABD-containing particles resulted in a 3-fold increase in 
plasma half-life compared to the naked ELR micelles. Moreover, the ABD-ELR-DOX 
nanoparticles demonstrated higher uptake by the tumor, hence reducing toxicity in other 
organs, like liver or spleen, and achieving a therapeutic effect with lower DOX doses. 
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Another issue when targeting tumors is the low uptake of drug-loaded nanoparticles by 
cells, thus limiting the activity of chemotherapeutic agents. In order to address this 
limitation, van Oppen et al. described the fusion of an octa-arginine peptide (R8) to an 
amphiphilic ELR, which promoted the uptake of the micelles by the cells in vitro [73]. 
This result sets the basis for the use of this R8-ELR for the delivery of antitumor drugs, 
although this work lacks evidence of in vivo performance. On the other hand, retention of 
delivery systems in mucus is a major challenge that was recently overcome by genetic 
conjugation of a hydrogel-forming ELR with a mucoadhesive peptide able to bind to 
transferrin receptors in the epithelial cell layer [74]. This DDS can be potentially used 
towards different mucosae, as demonstrated by in vitro and in vivo results. 
ELR-based vaccines 
Vaccination has also been explored as an opportunity to extend the applications of ELRs 
in the biomedical field. Specifically, García-Arévalo et al. described the fusion of an 
antigenic sequence from a major membrane protein of Mycobacterium tuberculosis to an 
amphiphilic ELR able to form stable nanoparticles [75]. In vivo immune-challenge 
experiments in mice showed the induction of a response similar to the one found upon 
vaccination, also highlighting the adjuvant effect of the ELR by itself. Likewise, Ingrole 
et al. designed an ELR fused to the M2e peptide, derived from the highly conserved 
extracellular domain of the influenza virus transmembrane protein [76]. This construction 
induced the production of a higher amount of M2e-specific serum antibodies in mice in 
comparison with the single M2e, thus enhancing the immunogenicity of the antigen. 
Another strategy has been recently reported, involving the fusion of an ELR to cytotoxic 
T lymphocyte (CTL) epitopes, which induce the activation of T cells and can be used for 
the treatment of many different diseases, including cancer. This fusion polypeptide 
allowed the binding of CTL epitopes to dendritic cells (DCs) directly in vivo, avoiding 
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the steps required for the extraction and CTL-loading of DCs ex vivo [77]. By also fusing 
a matrix metalloproteinase (MMP)-sensitive peptide and an albumin-binding domain, the 
accumulation of the carrier in lymph nodes was increased by 4-fold and the immune 
response towards the CTL was improved by 1.5-fold. 
ELR-mediated gene delivery 
Regarding gene delivery, few examples have arisen involving the use of ELRs as 
transfection agents to substitute other chemical methods and viral vectors, which raise 
some safety concerns. In a first work, Piña et al. described the use of a cationic ELR fused 
to the LAEL fusogenic peptide, which improves cellular uptake, to form polyplexes with 
plasmid DNA (pDNA) [78], resulting in an enhanced transfection efficiency compared to 
the pDNA by itself. In a subsequent study, they conjugated the ELR to an aptamer (short 
oligonucleotides that can bind molecules with high affinity and selectivity) towards 
MUC1, a membrane glycoprotein overexpressed in epithelial tumors, such as breast 
cancer [79]. Therefore, this strategy permitted the specific targeting of breast cancer cells 
for transfection with toxic agents able to kill tumor cells. Another recent example showed 
the generation of induced pluripotent stem cells by delivering the four factors described 
by Yamanaka for such purpose, i.e. Oct-4, Klf4, c-myc and Sox2, with an ELR-based 
transfection method, thus avoiding viral vectors [80]. Nevertheless, the aforementioned 
examples need to overcome some issues, such as lower transfection efficiency and higher 
cost than the widely used polyethylenimine (PEI). 
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ELRs as biomaterials for tissue engineering and regenerative medicine (TERM) 
ELR hydrogels 
In the last years, ELRs have been used as biomaterials for the development of hydrogels 
formed through different cross-linking methods. Specifically, our group has described the 
covalent cross-linking of ELRs by catalyst-free (i.e. copper-free) click chemistry [81], 
termed 1,3-dipolar cycloaddition, which is basically an azide-alkyne cycloaddition, 
taking advantage of the modification of amine groups present in the side chains of lysines. 
These hydrogels are very promising, since they have shown good in vitro and in vivo 
biocompatibility [82]. Macroporous scaffolds have been also achieved with this strategy, 
expanding the use of these ‘click’ hydrogels to applications where a highly porous 
structure is needed [83]. Similarly, other covalent cross-linking methods have been 
developed, using residues other than lysine for the cross-linking, such as tyrosine or 
cysteine [84, 85]. On the other hand, non-covalently cross-linked ELR hydrogels have 
also been developed [55, 71, 86]. All these hydrogels are good candidates as implants for 
enhanced tissue regeneration, considering the properties of the ELRs, and some of them 
have already been used for this purpose, as described below. 
ELRs for enhancing implant vascularization 
One of the major challenges concerning hydrogels and other tissue-engineered constructs 
is that they need to be vascularized to achieve a successful grafting upon implantation. 
The lack of vascularization implies an inability to provide adequate nutrient transport 
during the initial phase after implantation, due to a lack of blood flow between the 
construct and the host tissue, thus precluding the survival of implanted and host cells 
inside the scaffold [87, 88]. Therefore, novel strategies for enhancing vascularization in 
engineered templates are essential to ensure their clinical translation [89]. 
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Particularly, ELR-based hydrogels, whose application in tissue engineering and 
regenerative medicine has significantly increased in the past few years, are characterized 
by potential angiogenic properties, which is an essential step for their integration with the 
host tissue when implanted or injected. Recently, Marsano and co-workers have studied 
the angiogenic activity of ELR-based hydrogels that included cell adhesion sequences 
such as the Arg-Gly-Asp (RGD) tri-peptide, which promotes the attachment of different 
cell types [90], and Arg-Glu-Asp-Val (REDV), a selective cell adhesion motif for 
endothelial cells [91]. These hydrogels also comprised proteolytic sites, namely the Val-
Gly-Val-Ala-Pro-Gly (VGVAPG) sequence, sensitive to elastolytic enzymes [92]. 
Overall, this study demonstrated the control of angiogenesis by modulating the presence 
of bioactive sequences within ELR-based hydrogels, as they favor the integration with 
the host tissue, as well as the beginning of the vascularization process [93]. Similarly, 
Alagoz et al. coated poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) scaffolds 
with ELRs containing REDV sequence, aiming for bone regeneration. This work shows 
that the presence of REDV motifs improves endothelial cell adhesion and growth in vitro, 
with a consequent enhancement of vascularization, which is an important event when 
facing bone regeneration [94]. As described above, Roberts et al. developed a complex 
system that consists in the combination of stimuli-responsive disordered ELRs and 
structurally stable polyalanine helices [54]. When injected subcutaneously in C57BL/6 
mice, this system formed a stable porous scaffold that was invaded by a high quantity of 
cells. This was identified as a mild inflammatory response at the first timepoints, but it 
was followed by a uniform vascularization, as observed by the formation of capillaries 
and some large vessels after 21 days post-injection. Hence, their ability to promote 
angiogenesis makes them optimal candidates for diverse applications in regenerative 
medicine. 
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An alternative approach to enhance vascularization in tissue engineering constructs relies 
on the use of growth factors that induce vascular organization and remodeling. Among 
them, the vascular endothelial growth factor (VEGF) plays a key role in the majority of 
angiogenic processes, namely by promoting endothelial cell proliferation and migration 
[95]. However, the use of VEGF is limited by the need of recombinant expression in 
eukaryotic cells, mainly mammalian, for its production, and by its low stability in 
solution. Thus, to overcome these limitations, new growth factor-mimetic peptides have 
been identified, which can be easily synthesized and chemically tethered to the constructs. 
For instance, Cai et al. conjugated the so-called QK peptide (a VEGF-mimetic peptide) 
within ELR hydrogels, without affecting their mechanical properties [96]. Different 
concentrations of this peptide, i.e. 10 nM, 1 μM and 100 μM, were studied using human 
umbilical vein endothelial cells (HUVECs) in vitro, demonstrating that, at low 
concentrations, the QK peptide promoted better cell adhesion and proliferation than 
higher concentrations, which inhibited their outgrowth. In a subsequent experiment, the 
QK peptide was tethered to ELR molecules at a concentration of 1 μM and they were 
injected intramuscularly in a hind limb zone in mice to form hydrogels in situ [97]. The 
results showed that the QK peptide enhanced the de novo formation of functional 
capillaries within the ELR construct, favoring cell survival and tissue growth in vivo. In 
summary, these studies provide an alternative approach to the use of growth factor 
proteins, such as VEGF, in angiogenesis signalling. 
Another important feature of engineered constructs that also affects vascularization is 
their biodegradation, which is known to regulate many cellular behaviors. Biomaterials 
with a controlled and predictable biodegradation are in high demand, and they should 
simultaneously provide mechanical support, biological signals and resist physiological 
loads during the early stages of implantation. Madl et al. demonstrated that the formation 
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of vascular-like structures depends on the number of cleavage sites in a polymer 
sequence, as well as on the changes of the construct architecture upon biodegradation 
[98]. In addition, protease-mediated degradation of biomaterials plays an important role 
in the development of 3D systems intended for tissue engineering, as it provides a more 
precise control on cell infiltration (Fig. 3). Recently, Straley et al. demonstrated that the 
kinetics and sensitivity to proteolytic cleavage of urokinase plasminogen activator (uPA) 
epitopes are different depending on the amino acid sequence [99]. For instance, the Gly-
Thr-Ala-Arg (GTAR) sequence shows a high sensitivity to proteolytic cleavage, giving a 
fast response, while the Asp-Arg-Ile-Arg (DRIR) sequence confers a low cleavage 
efficiency, resulting in slower degradation kinetics. In another related work, Flora et al. 
evaluated the spatiotemporal control of cell infiltration in a 3D hydrogel that consists of 
a sandwich-like three-layer disc made of two different protease-sensitive ELRs that 
included the aforementioned proteolytic sequences (Flora et al., in press). This 3D 
construct was implanted subcutaneously in mice and the spatiotemporal progression of 
cell invasion was studied for twelve weeks. It was observed that cell infiltration 
progressed through an inside-to-outside pattern, meaning that the central layer of the 3D 
system, which is formed by the GTAR-ELR (characterized by a fast degradation rate), 
was first colonized, degraded and vascularized. Subsequently, the external layers made 
of DRIR-ELR (slow degradation rate) were invaded and degraded mainly by the cells that 
migrated from the inner part of the construct. This study offers new opportunities for the 
generation of tunable biodegradable systems that closely mimic complex biological 
structures, such as organoids or organs, and that can be implemented in tissue engineering 
and regenerative medicine. 
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Fig. 3. Graphical representation of ELR-based hydrogels with protease-sensitive and cell 
adhesion domains injected subcutaneously in mice. Due to their bioactivity, cells would 
be able to infiltrate over time, even forming vessel-like structures, which is indicative of 
angiogenesis. 
TERM applications of ELR hydrogels 
ELR-based hydrogels have been used in cardiovascular applications, taking advantage of 
their features, such as stable mechanical properties under physiological pressure and flow 
conditions, elasticity, biocompatibility and hemocompatibility, which make them good 
candidates in this field [100]. For instance, Gonzalez de Torre et al. covered metal stents 
with ELR-catalyst-free click gels that presented different bioactive sequences, promoting 
endothelialisation (formation of native endothelium) in less than 2 weeks in vitro [101]. 
When exposed to blood flow in dynamic conditions, minimal platelet adhesion and 
fibrinogen adsorption were detected on the surface of the ELR-covered stents, showing 
high hemocompatibility. Thus, this method represents an effective approach to obtain bio-
stents that prevent the formation of an atherosclerotic plaque. Moreover, different ELRs 
have been used to fabricate vascular grafts. Specifically, Mahara et al. developed a small-
calibre blood vessel made of ELR-based hydrogels reinforced with poly(lactic acid) 
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nanofibers as a new therapeutic strategy for reconstructive surgery [102]. When 
implanted in vivo, the tubular scaffold showed a rapid tissue regeneration with a high 
patency, maintaining a physiologic blood flow without thrombogenicity. Furthermore, 
Inostroza-Brito et al. fabricated geometrically complex structures, namely tubes, through 
spatiotemporally controlled self-assembly. For this purpose, peptide amphiphiles (PAs) 
were employed to guide the assembly of a larger protein, i.e. an ELR, into self-growing 
tubes. These structures promoted mouse-adipose-derived stem cells (mADSCs) and 
HUVECs adhesion and proliferation, due to the presence of bioactive RGD motifs coded 
within the ELR backbone. Therefore, these biomimetic tubes could be implemented in 
cardiovascular tissue engineering for the achievement of vascular implants [103]. 
Musculoskeletal tissues have also been proposed as targets for ELR hydrogels-mediated 
regeneration. In this regard, some in vitro tests have suggested the potential application 
of cartilage with a silk-elastin-like recombinamer [104], and bone with pro-mineralizing 
ELRs [105, 106]. Moreover, a non-covalently cross-linked bioactive ELR-based 
hydrogel, in combination with human mesenchymal stem cells, has been used to 
successfully regenerate an osteochondral defect in rabbits, showing even the formation 
of hyaline-like cartilage [107]. On the other hand, bone defects have been also treated 
with bioactive and biodegradable ELR-based hydrogels formed with an ELR fused to the 
bone morphogenetic protein-2 (BMP-2), which is a very powerful osteogenic factor. In 
this case, fully repaired defects were found after 3 months, showing the good performance 
of the hydrogels to promote this regeneration [108]. 
ELRs have also aimed for the regeneration of neural tissue, although short steps have 
been taken towards it up until now. In one work, Johnson et al. genetically fused two 
different neurotrophins to an ELR, separately: the nerve growth factor (NGF) and the 
brain-derived neurotrophic factor (BDNF), which could be potentially used for the 
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stimulation of neural regeneration both in vitro and in vivo [109]. In another work, S.C. 
Heilshorn and co-workers found that the maintenance of stemness in neural progenitor 
cells needs a scaffold (i.e. a hydrogel) that is able to be biodegraded over time, simulating 
matrix remodeling [110]. 
Although several elastin-based materials, composed of tropoelastin or α-elastin, among 
other versions of elastin, have been designed for wound healing applications, not so many 
ELRs have been postulated in this regard [24]. Recently, our group obtained oriented 
electrospun clickable ELR fibers, which have proven good cytocompatibility with 
fibroblasts and keratinocytes in vitro, suggesting their potential application in the 
formation of artificial skin or to promote skin regeneration [111]. Contemporarily, 
Fernández-Colino et al. achieved similar fibers, which highlights their ease of attainment 
and their potential application in different tissue engineering fields [112]. 
Other designs and applications of ELRs 
In addition to the aforementioned designs and applications of ELRs, other interesting uses 
have been explored in the last years. For instance, there are different works describing the 
design of ELRs for antibody precipitation as an alternative to chromatography [113, 114]. 
Moreover, hydrogels containing ELRs have been developed to study and modulate cell 
behavior in 3D cultures through the incorporation of different ligand chemistries or by 
tuning the stiffness of the scaffolds [115, 116]. On the other hand, fluorescent proteins 
have been fused to ELRs, enabling the study and prediction of self-assembly of diverse 
ELR constructs when genetically conjugated to large proteins [117], or even being 
proposed as potential Förster resonance energy transfer (FRET)-paired biosensors [118]. 
Another novel design proved the use of an ELR as a cytocompatible underwater adhesive 
intended for biomedical applications by the incorporation of the non-canonical amino 
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acid 3,4-dihydroxyphenylalanine (DOPA), which mimics the adhesion of mussels to 
surfaces [119]. Additionally, Yang et al. described how the genetic incorporation of the 
self-assembling peptide RADA-16 led to the obtaining of a hemostatic sponge able to 
stop the bleeding of wounds in mice [120]. 
Furthermore, it is also noteworthy the increasing number of works describing the 
combination of ELRs with other polymers or structural proteins, giving blends or 
biohybrids that recapitulate the properties of all the components. The first, and probably 
the most exploited blend, came from the recombinant fusion of ELRs with silk-like 
domains to give silk-elastin-like recombinamers (SELRs) that are able to form fibers and 
hydrogels, among other structures, whose stability relies on the β-sheet cross-linking 
between silk-like motifs [8, 71, 121-123]. Collagen-like peptides have also been explored 
as partners of ELRs in a recombinant way [124], even achieving nanoplatelets [125]. 
Furthermore, other non-polypeptide polymers have been combined with ELRs, including 
the widely used polyethylene glycol (PEG) [126, 127], inorganic bioglass [128], 
hyaluronic acid (HA) [129], self-assembling peptides [130], and lipids [131]. All these 
examples highlight the interest of using ELRs in combination with other biomaterials to 
obtain superior structures, such as hydrogels, that recapitulate the properties of their 
components, hence getting closer to the complexity of biological tissues and matrices. 
Final considerations 
Elastin-like recombinamers have gained an increasing interest during the last decades, 
with a great boost in the past few years, as highlighted by data: there are more PUBMED-
indexed publications regarding ELRs issued during the last five years than in all the 
previous years since their discovery. This fact has enormous implications, since it means 
that ELRs are currently being thoroughly investigated from different points of view, 
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elucidating their molecular mechanisms of self-assembly and shedding further light on 
their physicochemical and mechanical properties. Furthermore, it also implies that many 
groups are designing and using novel or already existing ELRs for still unexplored 
applications, broadening their scientific impact, and probably getting them closer to be 
translated into clinics as biomaterials. In this review, we have gathered multiple recent 
examples that reflect this interest in different fields, from the basic research of the 
physicochemical properties of ELRs and their consideration as IDPs/IDRs, to the several 
applications where they have found uses, including drug, vaccine and gene delivery, and 
TERM. All these examples provide convincing evidences of the high potential of ELRs 
as biomaterials, and encourage further investigation that may lead to consider them as a 
benchmark in the biomedical field. 
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